WASHINGTON, DC (July 17, 2018) – Today, the American Hospital A
340B Drug Pricing Program Press Releases
Latest
Contact: Marie Johnson, (202) 626-2351
Colin Milligan, (202) 638-5491
Today, the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC) and America's Essential Hospitals filed a lawsuit against the U.S. Department of Health and Human Services (HHS) in the U.S. District Court for the District of Columbia to prevent significant Medicare payment cuts for hospitals that participate in the 340B Drug Pricing Program.
CMS’s decision in today’s rule to cut Medicare payments to hospitals for drugs covered under the 340B program will dramatically threaten access to health care for many patients, including uninsured and other vulnerable populations. It is not based on sound policy and punishes hospitals and patients for participation in a program outside of CMS’s jurisdiction.
Today, CMS issued several poorly designed policies that will do real damage to patients access to care.
The skyrocketing price of prescription drugs threatens both patient access to care and the ability of providers to deliver the highest quality of care to patients and communities.
New analysis finds inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015.